Quality of life and follow-up of germ cell tumor patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034807

Enrollment

500

Registered

2024-08-16

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C62

Interventions

Group 1: It is an open prospective multicenter observational study of germ cell tumor patients. As part of the initial diagnosis, germ cell tumor patients receive a questionnaire to assess tumor-speci

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Patients who will be treated for a germ cell tumor in the Urology at the University Hospital Dresden -to give consent and written consent

Exclusion criteria

Exclusion criteria: -lack of compliance

Design outcomes

Primary

Measure	Time frame
Quality of life of germ cell tumor patients according to the EORTC-QLQ-TC26 (questionnaire) at the earliest 2 years after therapy	—

Secondary

Measure	Time frame
Follow-up of germ cell tumor patients Utilization of cryopreservation	—

Countries

Germany

Contacts

Public ContactMartin Baunacke

Klinik und Poliklinik für Urologie

martin.baunacke@ukdd.de+4935145818944

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026